Fathom Therapeutics Secures $47 Million Series A Funding for AI-driven Drug Molecule Design

Fathom Therapeutics, previously known as Atommap Corp., has raised an oversubscribed $47 million in Series A financing, led by Sutter Hill Ventures.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here